Nano-Hydroxyapatite Doped with Ho-166 as Drug Delivery System for Bone Cancer Therapy and Diagnosis: Developing a Theragnostic Radiopharmaceuticals

Author(s): Franciana Maria Rosa da Silva , Julio Cezar de Almeida , Elizabeth Eugenio de Mello Oliveira , Marta de Souza Albernaz , Alexandre Malta Rossi , Ralph Santos-Oliveira .

Journal Name: Anti-Cancer Agents in Medicinal Chemistry

Volume 17 , Issue 3 , 2017

Become EABM
Become Reviewer

Graphical Abstract:


Background: The use of nanobiomaterials is increasing each day. Among the immense variety of nanomaterials developed and studied the hydroxyapatite is one of the most ones.

Objective: In this study we developed and tested nano-hydroxyapatite dopped with Ho-166 for bone cancer.

Results: The results showed that the nano-hydroxyapatite dopped with Ho-166 has a great affinity for the bone.

Conclusion: The pre-clinical studies support the use as a nano-radiopharmaceuticals for bone cancer treatment and diagnosis.

Keywords: Radiopharmaceuticals, nanotechnology, oncology, scanning electron microscopy, transmission electron microscopy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [355 - 358]
Pages: 4
DOI: 10.2174/1871520616666151110130428
Price: $58

Article Metrics

PDF: 29